Sexual Wellness Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Sexual Wellness Market is segmented by Product Type (Contraceptives, Sexual Enhancement Products, and Sexual Health Devices), Distribution Channel (Pharmacies and Drugstores, E-commerce and Online Retail, Specialty Stores, and Clinics and Healthcare Facilities), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Sexual Wellness Market Size

Sexual Wellness Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 6.80 %
Fastest Growing Market Asia
Largest Market North America
Market Concentration Medium

Major Players

Sexual Wellness Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Sexual Wellness Market Analysis

The COVID-19 pandemic had an adverse effect on the market. As per the report published by the Centers for Disease Control and Prevention in April 2021, it reported during the start of the pandemic, sexually transmitted diseases decreased due to disruptions to health care and sexually transmitted infection testing services. The limited access to diagnoses and testing had supposedly decreased the spread of infection. However, as the clinics reopen, infection rates are again on the rise. In addition, interruption in the provision of reproductive health services during the pandemic resulted in a lack of access to contraceptives leading to unplanned pregnancies and abortions in India. According to the article published in April 2022 in Springer Nature, during the period April 2020-June 2020, a 43% drop in injectable contraceptives, a 50% drop in intra-uterine devices (IUDs), and a 21% drop in oral contraceptives was observed in India as compared to the same period in pre-pandemic days. Thus, such a decline in sales adversely hampered the studied market.

Furthermore, due to the rise in fertility among Indian rural women, the government is focused on family planning programs and providing devices as essential medicines. As per a press release by the MOHFW in September 2022, both types of IUDs were included in the essential medicines list for 2022. Thus, such initiatives and engagement of the government are anticipated to increase the demand for IUD devices, further driving the segment's growth.

Factors such as the increasing prevalence of sexual diseases coupled with increasing awareness programs are expected to increase market growth. The report published by the World Health Organization in November 2021 reported that more than 1.0 million sexually transmitted infections are acquired globally, and most of them are asymptomatic. It also reported that every year there are an estimated 374.0 million new infections, with 1 out of 4 sexually transmitted infections: gonorrhea, chlamydia, trichomoniasis, and syphilis. Similarly, according to the report published by the European Centre for Disease Prevention and Control in March 2021, it reported that every year around 500,000 sexually transmitted infections are detected in the European Union, European Economic Area (EEA), and the United Kingdom.

Additionally, screening programs by the governments increase awareness related to sexual diseases and are expected to increase the adoption of sexual wellness products. For instance, in March 2022, National Chlamydia Screening Program (NCSP) was organized in the United Kingdom. The objective of the program is to reduce the risk of untreated chlamydia infection. Additionally, the program focuses on reducing the time to test results and treatment and re-testing after treatment. The program is also changing from prevention and control to focusing on reducing the harms of untreated chlamydia infection by primarily screening women and girls.

Similarly, in June 2022, the Centers for Disease Control and Prevention recommended and issued guidelines for screening sexually transmitted diseases to create awareness towards screening programs for STDs and the increasing burden of STDs across the globe. Thus, the increasing prevalence of sexual diseases and growing awareness about sexual health are driving the adoption of sexual wellness products. Prevention of sexual diseases and promotion of responsible sexual behavior contribute to the increased use of contraceptives. Education initiatives and reduced stigma surrounding sexual health encourage individuals to seek and adopt sexual wellness products. Improved accessibility and availability of these products further contribute to their growing adoption.

Sexual Wellness Market Trends

Contraceptives Segment is Expected to Hold a Significant Market Share Over the Forecast Period

Factors such as the increasing prevalence of sexual diseases, coupled with product launches and approvals, are expected to increase segmental growth. For instance, in November 2021, a report published by the European Centre for Disease Prevention and Control stated that the sex between men and women is the second most commonly reported mode of transmission in the European Union, accounting for 29.7% (4445) of all HIV diagnoses. The highest proportions of these were observed in France (53%). Thus, the high prevalence in France of HIV diagnosis is expected to increase the market growth over the forecast period. Additionally, as per National Family Health Survey (NFHS) report 2021, nearly 37.9% of women in India use sterilization to prevent unwanted pregnancies, much higher than non-surgical methods, and India shows heterogeneous geographical variation in the choice of contraceptive methods for family planning and controls the abortions coupled with unwanted pregnancies. Increased awareness of safe sex practices in France is likely to drive demand for barrier contraceptives, while the need for alternative contraceptive options in India presents an opportunity for non-surgical methods. The geographic variation in contraceptive preferences in India emphasizes the need for a diverse range of products.

Product launches and approvals are expected to increase market growth. For instance, in April 2021, Mayne Pharma received Food and Drug Administration (FDA) approval for NEXTSTELLIS (3 mg drospirenone (DRSP) and 14.2 mg estetrol [E4] tablets) for the prevention of pregnancy. Similarly, in February 2021, Evofem Biosciences, Inc., launched "Get Phexxi," a national direct-to-consumer (DTC) campaign aimed at broadening awareness of its non-hormonal. Thus, the increased demand for contraceptive products is expected to increase segmental growth.

Sexual Wellness Market: Estimated Quantities of Contraceptive Devices Procured for Supply to States (In Millions), by Type, India, 2021-2022

North America is Expected to Hold a Significant Share in the Market Over the Forecast Period

Factors such as the increasing prevalence of sexual diseases, research grants, and product initiatives such as approvals and launches are expected to increase market growth in the North American region. Increasing research grants are expected to increase market growth in the region. For instance, According to the Department of Health & Human Services, approximately 1.2 million people in the United States have HIV, and about 13% are unaware and need testing.

Similarly, the allocation of USD 117 million from the CDC to state and local health authorities in July 2021 for HIV prevention and treatment activities is expected to significantly impact the growth of the sexual wellness market. This funding supports the government's Ending the HIV Epidemic in the US (EHE) project, which aims to expand and customize essential HIV prevention strategies in 57 priority areas. As a result of increased funding and support for HIV prevention and treatment, there will be a greater emphasis on education, awareness, and access to sexual wellness products. This will drive the demand for products such as condoms, barrier methods, and other preventive measures. Additionally, the research grants enable expanding healthcare infrastructure and enhancing sexual health services, leading to increased availability and accessibility of sexual wellness products. In conclusion, the CDC research grants for HIV prevention and treatment activities will stimulate the growth of the sexual wellness market by promoting education, awareness, access, and customization of HIV prevention strategies, ultimately benefiting individuals seeking comprehensive sexual health services.

Product approval is another factor in market growth. For instance, in March 2021, Mithra and Searchlight Pharma received Health Canada approval for Nextstellis, the first and only combined oral contraceptive (COC) product based on the unique native estrogen estetrol (E4). Thus, the increasing prevalence of STDs, coupled with grants and product approvals, is expected to increase market growth.

Sexual Wellness Market - Growth Rate by Region

Sexual Wellness Industry Overview

The sexual wellness market is expected to be moderately fragmented, with several key players in the market. Various strategies, such as the acquisition of the products by other companies, consolidate the market positions across the globe. Some major players include Reckitt Benckiser Group plc, Pfizer Inc., Bayer AG, CooperSurgical Inc., and Eli Lilly and Company, among others.

Sexual Wellness Market Leaders

  1. Reckitt Benckiser Group plc

  2. Pfizer Inc.

  3. Bayer AG

  4. CooperSurgical Inc.

  5. Eli Lilly and Company

*Disclaimer: Major Players sorted in no particular order

Sexual Wellness Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Sexual Wellness Market News

  • March 2023: NEXT Life Sciences, Inc. (NEXT) launched a new contraceptive product for men to market; Plan A. NEXT is developing Plan A to be a safe, effective, fully reversible birth control solution for men.
  • May 2022: Mayne Pharma Group Limited entered into a new strategic collaboration with GoodRx. The collaborative initiative will deliver an enhanced direct-to-consumer program aimed at building awareness of NEXTSTELLIS oral contraceptive availability in the United States.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Awareness and Education

      2. 4.2.2 Rising Incidence of Sexual Health Disorders

      3. 4.2.3 Technological Advancements in Product Innovation

    3. 4.3 Market Restraints

      1. 4.3.1 Social Stigma and Taboos

      2. 4.3.2 Stringent regulations Related to the Sale and distribution of Sexual Wellness Products

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 5.1 By Product Type

      1. 5.1.1 Contraceptives

      2. 5.1.2 Sexual Enhancement Products

      3. 5.1.3 Sexual Health Devices

    2. 5.2 By Distribution Channel

      1. 5.2.1 Pharmacies and Drugstores

      2. 5.2.2 E-Commerce and Online Retail

      3. 5.2.3 Specialty Stores

      4. 5.2.4 Clinics and Healthcare Facilities

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bayer AG

      2. 6.1.2 Besins Healthcare

      3. 6.1.3 Church & Dwight Co., Inc.

      4. 6.1.4 CooperSurgical Inc.

      5. 6.1.5 Eli Lilly and Company

      6. 6.1.6 Endo International plc

      7. 6.1.7 Karex Berhad.

      8. 6.1.8 KESSEL medintim GmbH

      9. 6.1.9 Organon

      10. 6.1.10 Pfizer Inc.

      11. 6.1.11 Reckitt Benckiser Group plc

      12. 6.1.12 TherapeuticsMD, Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments in that box
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Sexual Wellness Industry Segmentation

As per the scope, the sexual wellness market aims to cater to individuals' sexual health needs by offering a diverse range of products and services while considering different distribution channels and regional variations. It focuses on promoting sexual well-being, providing options for contraception, addressing sexual health concerns, and improving overall sexual experiences. The Sexual Wellness Market is segmented by Product Type (Contraceptives, Sexual Enhancement Products, and Sexual Health Devices), Distribution Channel (Pharmacies and Drugstores, E-commerce and Online Retail, Specialty Stores, and Clinics and Healthcare Facilities), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type
Contraceptives
Sexual Enhancement Products
Sexual Health Devices
By Distribution Channel
Pharmacies and Drugstores
E-Commerce and Online Retail
Specialty Stores
Clinics and Healthcare Facilities
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Frequently Asked Questions

The Sexual Wellness Market is projected to register a CAGR of 6.80% during the forecast period (2024-2029)

Reckitt Benckiser Group plc, Pfizer Inc., Bayer AG, CooperSurgical Inc. and Eli Lilly and Company are the major companies operating in the Sexual Wellness Market.

Asia is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Sexual Wellness Market.

The report covers the Sexual Wellness Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Sexual Wellness Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Sexual Wellness Industry Report

Statistics for the 2024 Sexual Wellness market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Sexual Wellness analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Sexual Wellness Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)